| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Rank | Journal Name | JCR Year | Abbreviated Journal | Publisher | ISSN | eISSN | Total Cites | Total Articles | Citable Items | Cited Half-Life | Citing Half-Life | JIF 2024 | 5-Year JIF | JIF Without Self-Cites | JCI | JIF Quartile | JIF Rank |
2 | 1 | CA-A CANCER JOURNAL FOR CLINICIANS | 2024 | CA-CANCER J CLIN | WILEY | 0007-9235 | 1542-4863 | 71799 | 6 | 14 | 3.7 | 4.7 | 232.4 | 353.0 | 232.2 | 112.16 | Q1 | 1/326 |
3 | 2 | NATURE REVIEWS MICROBIOLOGY | 2024 | NAT REV MICROBIOL | NATURE PORTFOLIO | 1740-1526 | 1740-1534 | 61109 | 0 | 49 | 6.7 | 5.4 | 103.3 | 99.1 | 102.8 | 9.86 | Q1 | 1/163 |
4 | 3 | NATURE REVIEWS DRUG DISCOVERY | 2024 | NAT REV DRUG DISCOV | NATURE PORTFOLIO | 1474-1776 | 1474-1784 | 52833 | 4 | 36 | 6.5 | 5.4 | 101.8 | 129.8 | 101.1 | 13.95 | Q1 | 1/352 |
5 | 3 | NATURE REVIEWS DRUG DISCOVERY | 2024 | NAT REV DRUG DISCOV | NATURE PORTFOLIO | 1474-1776 | 1474-1784 | 52833 | 4 | 36 | 6.5 | 5.4 | 101.8 | 129.8 | 101.1 | 13.95 | Q1 | 1/352 |
6 | 4 | NATURE REVIEWS MOLECULAR CELL BIOLOGY | 2024 | NAT REV MOL CELL BIO | NATURE PORTFOLIO | 1471-0072 | 1471-0080 | 73135 | 0 | 49 | 7.1 | 6.9 | 90.2 | 128.7 | 89.6 | 7.94 | Q1 | 1/204 |
7 | 5 | Kidney International Supplements | 2024 | KIDNEY INT SUPPL | ELSEVIER SCIENCE INC | 2157-1724 | 2157-1716 | 3196 | 9 | 9 | 11.0 | 5.6 | 89.6 | 26.0 | 89.6 | 5.88 | Q1 | 1/133 |
8 | 6 | LANCET | 2024 | LANCET | ELSEVIER SCIENCE INC | 0140-6736 | 1474-547X | 347563 | 198 | 251 | 7.8 | 4.5 | 88.5 | 104.8 | 87.1 | 23.28 | Q1 | 1/332 |
9 | 7 | Nature Reviews Materials | 2024 | NAT REV MATER | NATURE PORTFOLIO | 2058-8437 | 2058-8437 | 43197 | 10 | 60 | 4.9 | 5.0 | 86.2 | 99.8 | 85.9 | 4.42 | Q1 | 1/460 |
10 | 7 | Nature Reviews Materials | 2024 | NAT REV MATER | NATURE PORTFOLIO | 2058-8437 | 2058-8437 | 43197 | 10 | 60 | 4.9 | 5.0 | 86.2 | 99.8 | 85.9 | 4.42 | Q1 | 1/460 |
11 | 8 | Nature Reviews Clinical Oncology | 2024 | NAT REV CLIN ONCOL | NATURE PORTFOLIO | 1759-4774 | 1759-4782 | 33355 | 3 | 48 | 4.6 | 4.6 | 82.2 | 89.9 | 81.7 | 11.95 | Q1 | 2/326 |
12 | 9 | NEW ENGLAND JOURNAL OF MEDICINE | 2024 | NEW ENGL J MED | MASSACHUSETTS MEDICAL SOC | 0028-4793 | 1533-4406 | 397323 | 246 | 293 | 8.4 | 5.3 | 78.5 | 84.9 | 77.9 | 23.30 | Q1 | 2/332 |
13 | 10 | Nature Reviews Earth & Environment | 2024 | NAT REV EARTH ENV | SPRINGERNATURE | N/A | 2662-138X | 14133 | 3 | 52 | 3.0 | 7.2 | 71.5 | 73.7 | 71.1 | 5.96 | Q1 | 1/374 |
14 | 10 | Nature Reviews Earth & Environment | 2024 | NAT REV EARTH ENV | SPRINGERNATURE | N/A | 2662-138X | 14133 | 3 | 52 | 3.0 | 7.2 | 71.5 | 73.7 | 71.1 | 5.96 | Q1 | 1/374 |
15 | 11 | NATURE REVIEWS CANCER | 2024 | NAT REV CANCER | NATURE PORTFOLIO | 1474-175X | 1474-1768 | 60054 | 17 | 63 | 9.4 | 5.4 | 66.8 | 81.0 | 66.4 | 9.04 | Q1 | 3/326 |
16 | 12 | World Psychiatry | 2024 | WORLD PSYCHIATRY | WILEY | 1723-8617 | 2051-5545 | 13954 | 21 | 21 | 6.3 | 6.4 | 65.8 | 60.0 | 60.7 | 12.18 | Q1 | 1/288 |
17 | 13 | ANNALS OF ONCOLOGY | 2024 | ANN ONCOL | ELSEVIER | 0923-7534 | 1569-8041 | 64093 | 74 | 80 | 6.3 | 4.3 | 65.4 | 46.8 | 64.5 | 8.38 | Q1 | 4/326 |
18 | 14 | Living Reviews in Relativity | 2024 | LIVING REV RELATIV | SPRINGER INT PUBL AG | 2367-3613 | 1433-8351 | 5042 | 0 | 6 | 11.0 | 13.3 | 62.5 | 52.4 | 62.5 | 5.86 | Q1 | 1/31 |
19 | 15 | NATURE REVIEWS IMMUNOLOGY | 2024 | NAT REV IMMUNOL | NATURE PORTFOLIO | 1474-1733 | 1474-1741 | 64754 | 76 | 124 | 8.6 | 6.8 | 60.9 | 77.6 | 60.5 | 7.86 | Q1 | 1/183 |
20 | 16 | Nature Reviews Disease Primers | 2024 | NAT REV DIS PRIMERS | NATURE PORTFOLIO | 2056-676X | 2056-676X | 37841 | 4 | 42 | 5.8 | 6.9 | 60.6 | 104.8 | 60.6 | 21.18 | Q1 | 3/332 |
21 | 17 | MMWR Recommendations and Reports | 2024 | MMWR RECOMM REP | CENTERS DISEASE CONTROL & PREVENTION | 1057-5987 | 1545-8601 | 3411 | 6 | 6 | 8.0 | 14.9 | 60.1 | 50.0 | 60.0 | 10.91 | Q1 | 1/419 |
22 | 17 | Nature Energy | 2024 | NAT ENERGY | NATURE PORTFOLIO | 2058-7546 | 2058-7546 | 55904 | 214 | 222 | 4.8 | 4.7 | 60.1 | 68.9 | 59.4 | 8.48 | Q1 | 2/460 |
23 | 17 | Nature Energy | 2024 | NAT ENERGY | NATURE PORTFOLIO | 2058-7546 | 2058-7546 | 55904 | 214 | 222 | 4.8 | 4.7 | 60.1 | 68.9 | 59.4 | 8.48 | Q1 | 2/460 |
24 | 19 | Nature Reviews Methods Primers | 2024 | NAT REV METHOD PRIME | SPRINGERNATURE | N/A | 2662-8449 | 9349 | 26 | 64 | 2.7 | 6.5 | 56.0 | 66.9 | 55.8 | 9.39 | Q1 | 1/135 |
25 | 20 | CHEMICAL REVIEWS | 2024 | CHEM REV | AMER CHEMICAL SOC | 0009-2665 | 1520-6890 | 246622 | 0 | 212 | 8.3 | 7.4 | 55.8 | 67.5 | 55.3 | 4.03 | Q1 | 1/239 |
26 | 21 | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024 | JAMA-J AM MED ASSOC | AMER MEDICAL ASSOC | 0098-7484 | 1538-3598 | 194087 | 180 | 232 | 8.6 | 5.5 | 55.0 | 64.7 | 53.9 | 11.47 | Q1 | 4/332 |
27 | 22 | Signal Transduction and Targeted Therapy | 2024 | SIGNAL TRANSDUCT TAR | SPRINGERNATURE | 2095-9907 | 2059-3635 | 51196 | 156 | 245 | 2.8 | 6.0 | 52.7 | 52.2 | 52.1 | 5.04 | Q1 | 1/319 |
28 | 22 | Signal Transduction and Targeted Therapy | 2024 | SIGNAL TRANSDUCT TAR | SPRINGERNATURE | 2095-9907 | 2059-3635 | 51196 | 156 | 245 | 2.8 | 6.0 | 52.7 | 52.2 | 52.1 | 5.04 | Q1 | 1/319 |
29 | 23 | NATURE REVIEWS GENETICS | 2024 | NAT REV GENET | NATURE PORTFOLIO | 1471-0056 | 1471-0064 | 42931 | 0 | 54 | 9.1 | 5.9 | 52.0 | 57.1 | 51.5 | 6.66 | Q1 | 1/191 |
30 | 24 | Nature Reviews Chemistry | 2024 | NAT REV CHEM | NATURE PORTFOLIO | N/A | 2397-3358 | 16326 | 0 | 48 | 4.1 | 6.4 | 51.7 | 49.4 | 51.4 | 3.28 | Q1 | 2/239 |
31 | 25 | Nature Reviews Gastroenterology & Hepatology | 2024 | NAT REV GASTRO HEPAT | NATURE PORTFOLIO | 1759-5045 | 1759-5053 | 30358 | 0 | 48 | 5.3 | 5.9 | 51.0 | 72.4 | 50.4 | 8.10 | Q1 | 1/147 |
32 | 26 | NATURE MEDICINE | 2024 | NAT MED | NATURE PORTFOLIO | 1078-8956 | 1546-170X | 133694 | 325 | 343 | 6.3 | 5.0 | 50.0 | 52.4 | 49.2 | 11.03 | Q1 | 1/195 |
33 | 26 | NATURE MEDICINE | 2024 | NAT MED | NATURE PORTFOLIO | 1078-8956 | 1546-170X | 133694 | 325 | 343 | 6.3 | 5.0 | 50.0 | 52.4 | 49.2 | 11.03 | Q1 | 1/195 |
34 | 26 | NATURE MEDICINE | 2024 | NAT MED | NATURE PORTFOLIO | 1078-8956 | 1546-170X | 133694 | 325 | 343 | 6.3 | 5.0 | 50.0 | 52.4 | 49.2 | 11.03 | Q1 | 1/195 |
35 | 27 | MMWR Surveillance Summaries | 2024 | MMWR SURVEILL SUMM | CENTERS DISEASE CONTROL & PREVENTION | 1545-8636 | 1545-8636 | 3499 | 3 | 3 | 6.1 | N/A | 49.8 | 34.1 | 49.8 | 15.95 | Q1 | 2/419 |
36 | 28 | NATURE | 2024 | NATURE | NATURE PORTFOLIO | 0028-0836 | 1476-4687 | 965275 | 1361 | 1393 | 10.0 | 7.2 | 48.5 | 55.0 | 47.7 | 11.12 | Q1 | 2/135 |
37 | 29 | IEEE Communications Surveys and Tutorials | 2024 | IEEE COMMUN SURV TUT | IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC | N/A | 1553-877X | 33160 | 74 | 74 | 5.2 | 5.2 | 46.7 | 42.8 | 45.6 | 10.20 | Q1 | 1/258 |
38 | 29 | IEEE Communications Surveys and Tutorials | 2024 | IEEE COMMUN SURV TUT | IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC | N/A | 1553-877X | 33160 | 74 | 74 | 5.2 | 5.2 | 46.7 | 42.8 | 45.6 | 10.20 | Q1 | 1/258 |
39 | 30 | SCIENCE | 2024 | SCIENCE | AMER ASSOC ADVANCEMENT SCIENCE | 0036-8075 | 1095-9203 | 785913 | 768 | 800 | 11.5 | 7.5 | 45.8 | 49.7 | 45.3 | 8.98 | Q1 | 3/135 |
40 | 31 | LANCET NEUROLOGY | 2024 | LANCET NEUROL | ELSEVIER SCIENCE INC | 1474-4422 | 1474-4465 | 52666 | 61 | 79 | 7.2 | 4.6 | 45.5 | 56.2 | 44.6 | 12.19 | Q1 | 1/285 |
41 | 32 | REVIEWS OF MODERN PHYSICS | 2024 | REV MOD PHYS | AMER PHYSICAL SOC | 0034-6861 | 1539-0756 | 65614 | 0 | 32 | 14.9 | 9.9 | 44.8 | 56.3 | 44.6 | 4.08 | Q1 | 1/114 |
42 | 33 | Nature Catalysis | 2024 | NAT CATAL | NATURE PORTFOLIO | 2520-1158 | 2520-1158 | 32070 | 156 | 165 | 4.1 | 6.5 | 44.6 | 47.4 | 44.2 | 5.63 | Q1 | 1/185 |
43 | 34 | CANCER CELL | 2024 | CANCER CELL | CELL PRESS | 1535-6108 | 1878-3686 | 56241 | 105 | 112 | 7.0 | 5.8 | 44.5 | 47.2 | 43.9 | 8.11 | Q1 | 5/326 |
44 | 34 | CANCER CELL | 2024 | CANCER CELL | CELL PRESS | 1535-6108 | 1878-3686 | 56241 | 105 | 112 | 7.0 | 5.8 | 44.5 | 47.2 | 43.9 | 8.11 | Q1 | 5/326 |
45 | 35 | Nature Reviews Cardiology | 2024 | NAT REV CARDIOL | NATURE PORTFOLIO | 1759-5002 | 1759-5010 | 22153 | 4 | 52 | 4.9 | 7.0 | 44.2 | 52.9 | 43.7 | 8.32 | Q1 | 1/230 |
46 | 36 | BMJ-British Medical Journal | 2024 | BMJ-BRIT MED J | BMJ PUBLISHING GROUP | 0959-535X | 1756-1833 | 173910 | 132 | 153 | 8.6 | 3.9 | 42.7 | 76.1 | 40.4 | 9.96 | Q1 | 5/332 |
47 | 37 | CELL | 2024 | CELL | CELL PRESS | 0092-8674 | 1097-4172 | 310873 | 357 | 409 | 9.3 | 7.3 | 42.5 | 48.9 | 41.9 | 7.99 | Q1 | 3/319 |
48 | 37 | CELL | 2024 | CELL | CELL PRESS | 0092-8674 | 1097-4172 | 310873 | 357 | 409 | 9.3 | 7.3 | 42.5 | 48.9 | 41.9 | 7.99 | Q1 | 3/319 |
49 | 38 | JOURNAL OF CLINICAL ONCOLOGY | 2024 | J CLIN ONCOL | LIPPINCOTT WILLIAMS & WILKINS | 0732-183X | 1527-7755 | 169483 | 342 | 365 | 7.8 | 5.9 | 41.9 | 37.7 | 41.1 | 6.68 | Q1 | 6/326 |
50 | 39 | Lancet Diabetes & Endocrinology | 2024 | LANCET DIABETES ENDO | ELSEVIER SCIENCE INC | 2213-8587 | 2213-8595 | 22003 | 56 | 67 | 5.1 | 5.3 | 41.8 | 41.7 | 41.1 | 8.50 | Q1 | 1/191 |
51 | 40 | NATURE BIOTECHNOLOGY | 2024 | NAT BIOTECHNOL | NATURE PORTFOLIO | 1087-0156 | 1546-1696 | 100474 | 256 | 265 | 6.9 | 5.8 | 41.7 | 59.5 | 41.0 | 8.57 | Q1 | 2/177 |
52 | 41 | Nature Electronics | 2024 | NAT ELECTRON | NATURE PORTFOLIO | 2520-1131 | 2520-1131 | 20582 | 146 | 156 | 3.8 | 5.3 | 40.9 | 42.0 | 40.1 | 5.80 | Q1 | 1/366 |
53 | 42 | Journal of Hematology & Oncology | 2024 | J HEMATOL ONCOL | BMC | N/A | 1756-8722 | 27071 | 33 | 79 | 4.1 | 4.9 | 40.4 | 34.4 | 40.0 | 5.04 | Q1 | 1/98 |
54 | 42 | Journal of Hematology & Oncology | 2024 | J HEMATOL ONCOL | BMC | N/A | 1756-8722 | 27071 | 33 | 79 | 4.1 | 4.9 | 40.4 | 34.4 | 40.0 | 5.04 | Q1 | 1/98 |
55 | 43 | Nature Reviews Endocrinology | 2024 | NAT REV ENDOCRINOL | NATURE PORTFOLIO | 1759-5029 | 1759-5037 | 23507 | 3 | 50 | 6.2 | 6.7 | 40.0 | 47.0 | 39.6 | 4.95 | Q1 | 2/191 |
56 | 43 | PROGRESS IN MATERIALS SCIENCE | 2024 | PROG MATER SCI | PERGAMON-ELSEVIER SCIENCE LTD | 0079-6425 | 1873-2208 | 36931 | 0 | 126 | 5.8 | 5.4 | 40.0 | 44.8 | 39.6 | 2.42 | Q1 | 3/460 |
57 | 45 | Nature Reviews Nephrology | 2024 | NAT REV NEPHROL | NATURE PORTFOLIO | 1759-5061 | 1759-507X | 19202 | 3 | 48 | 5.3 | 6.9 | 39.8 | 44.5 | 39.3 | 7.36 | Q1 | 2/133 |
58 | 46 | Nature Reviews Physics | 2024 | NAT REV PHYS | NATURE PORTFOLIO | N/A | 2522-5820 | 12208 | 0 | 48 | 3.6 | 6.4 | 39.5 | 53.2 | 39.2 | 3.03 | Q1 | 1/187 |
59 | 46 | Nature Reviews Physics | 2024 | NAT REV PHYS | NATURE PORTFOLIO | N/A | 2522-5820 | 12208 | 0 | 48 | 3.6 | 6.4 | 39.5 | 53.2 | 39.2 | 3.03 | Q1 | 1/187 |
60 | 47 | CHEMICAL SOCIETY REVIEWS | 2024 | CHEM SOC REV | ROYAL SOC CHEMISTRY | 0306-0012 | 1460-4744 | 183460 | 0 | 309 | 7.4 | 5.8 | 39.0 | 50.1 | 38.6 | 2.95 | Q1 | 3/239 |
61 | 48 | CIRCULATION | 2024 | CIRCULATION | LIPPINCOTT WILLIAMS & WILKINS | 0009-7322 | 1524-4539 | 177978 | 246 | 310 | 10.5 | 6.5 | 38.6 | 35.9 | 37.7 | 9.01 | Q1 | 1/98 |
62 | 48 | CIRCULATION | 2024 | CIRCULATION | LIPPINCOTT WILLIAMS & WILKINS | 0009-7322 | 1524-4539 | 177978 | 246 | 310 | 10.5 | 6.5 | 38.6 | 35.9 | 37.7 | 9.01 | Q1 | 1/98 |
63 | 48 | Lancet Gastroenterology & Hepatology | 2024 | LANCET GASTROENTEROL | ELSEVIER INC | N/A | 2468-1253 | 16102 | 52 | 68 | 3.7 | 4.9 | 38.6 | 34.0 | 38.1 | 6.90 | Q1 | 2/147 |
64 | 50 | NATURE MATERIALS | 2024 | NAT MATER | NATURE PORTFOLIO | 1476-1122 | 1476-4660 | 115316 | 271 | 281 | 8.3 | 6.7 | 38.5 | 46.8 | 38.2 | 5.99 | Q1 | 1/79 |
65 | 50 | NATURE MATERIALS | 2024 | NAT MATER | NATURE PORTFOLIO | 1476-1122 | 1476-4660 | 115316 | 271 | 281 | 8.3 | 6.7 | 38.5 | 46.8 | 38.2 | 5.99 | Q1 | 1/79 |
66 | 50 | NATURE MATERIALS | 2024 | NAT MATER | NATURE PORTFOLIO | 1476-1122 | 1476-4660 | 115316 | 271 | 281 | 8.3 | 6.7 | 38.5 | 46.8 | 38.2 | 5.99 | Q1 | 1/79 |
67 | 50 | NATURE MATERIALS | 2024 | NAT MATER | NATURE PORTFOLIO | 1476-1122 | 1476-4660 | 115316 | 271 | 281 | 8.3 | 6.7 | 38.5 | 46.8 | 38.2 | 5.99 | Q1 | 1/79 |
68 | 51 | Nature Reviews Bioengineering | 2024 | NAT REV BIOENG | SPRINGERNATURE | N/A | 2731-6092 | 2516 | 1 | 72 | 1.3 | 5.7 | 37.6 | 37.6 | 36.8 | 3.25 | Q1 | 1/124 |
69 | 51 | Nature Reviews Bioengineering | 2024 | NAT REV BIOENG | SPRINGERNATURE | N/A | 2731-6092 | 2516 | 1 | 72 | 1.3 | 5.7 | 37.6 | 37.6 | 36.8 | 3.25 | Q1 | 1/124 |
70 | 52 | REVIEWS OF GEOPHYSICS | 2024 | REV GEOPHYS | AMER GEOPHYSICAL UNION | 8755-1209 | 1944-9208 | 18402 | 0 | 15 | 12.8 | 9.1 | 37.3 | 34.6 | 37.2 | 3.26 | Q1 | 1/100 |
71 | 53 | PROGRESS IN ENERGY AND COMBUSTION SCIENCE | 2024 | PROG ENERG COMBUST | PERGAMON-ELSEVIER SCIENCE LTD | 0360-1285 | 1873-216X | 18841 | 0 | 27 | 7.8 | 7.9 | 37.0 | 39.3 | 36.8 | 2.67 | Q1 | 1/175 |
72 | 53 | PROGRESS IN ENERGY AND COMBUSTION SCIENCE | 2024 | PROG ENERG COMBUST | PERGAMON-ELSEVIER SCIENCE LTD | 0360-1285 | 1873-216X | 18841 | 0 | 27 | 7.8 | 7.9 | 37.0 | 39.3 | 36.8 | 2.67 | Q1 | 1/175 |
73 | 53 | PROGRESS IN ENERGY AND COMBUSTION SCIENCE | 2024 | PROG ENERG COMBUST | PERGAMON-ELSEVIER SCIENCE LTD | 0360-1285 | 1873-216X | 18841 | 0 | 27 | 7.8 | 7.9 | 37.0 | 39.3 | 36.8 | 2.67 | Q1 | 1/175 |
74 | 53 | PROGRESS IN ENERGY AND COMBUSTION SCIENCE | 2024 | PROG ENERG COMBUST | PERGAMON-ELSEVIER SCIENCE LTD | 0360-1285 | 1873-216X | 18841 | 0 | 27 | 7.8 | 7.9 | 37.0 | 39.3 | 36.8 | 2.67 | Q1 | 1/175 |
75 | 54 | eScience | 2024 | ESCIENCE | KEAI PUBLISHING LTD | 2097-2431 | 2667-1417 | 5679 | 40 | 63 | 1.8 | 4.7 | 36.6 | 35.9 | 35.9 | 5.58 | Q1 | 5/460 |
76 | 54 | eScience | 2024 | ESCIENCE | KEAI PUBLISHING LTD | 2097-2431 | 2667-1417 | 5679 | 40 | 63 | 1.8 | 4.7 | 36.6 | 35.9 | 35.9 | 5.58 | Q1 | 5/460 |
77 | 55 | Nano-Micro Letters | 2024 | NANO-MICRO LETT | SHANGHAI JIAO TONG UNIV PRESS | 2311-6706 | 2150-5551 | 35542 | 186 | 266 | 2.6 | 4.2 | 36.3 | 30.1 | 34.6 | 5.04 | Q1 | 2/147 |
78 | 55 | Nano-Micro Letters | 2024 | NANO-MICRO LETT | SHANGHAI JIAO TONG UNIV PRESS | 2311-6706 | 2150-5551 | 35542 | 186 | 266 | 2.6 | 4.2 | 36.3 | 30.1 | 34.6 | 5.04 | Q1 | 2/147 |
79 | 55 | Nano-Micro Letters | 2024 | NANO-MICRO LETT | SHANGHAI JIAO TONG UNIV PRESS | 2311-6706 | 2150-5551 | 35542 | 186 | 266 | 2.6 | 4.2 | 36.3 | 30.1 | 34.6 | 5.04 | Q1 | 2/147 |
80 | 55 | Electrochemical Energy Reviews | 2024 | ELECTROCHEM ENERGY R | SPRINGERNATURE | 2520-8489 | 2520-8136 | 5833 | 0 | 34 | 3.3 | 5.4 | 36.3 | 34.1 | 35.7 | 2.36 | Q1 | 2/44 |
81 | 57 | LANCET ONCOLOGY | 2024 | LANCET ONCOL | ELSEVIER SCIENCE INC | 1470-2045 | 1474-5488 | 74077 | 140 | 168 | 6.7 | 4.7 | 35.9 | 42.0 | 35.3 | 8.68 | Q1 | 8/326 |
82 | 58 | EUROPEAN HEART JOURNAL | 2024 | EUR HEART J | OXFORD UNIV PRESS | 0195-668X | 1522-9645 | 90583 | 264 | 340 | 5.7 | 5.2 | 35.6 | 34.4 | 32.6 | 8.05 | Q1 | 3/230 |
83 | 59 | Joule | 2024 | JOULE | CELL PRESS | 2542-4351 | 2542-4351 | 44869 | 146 | 183 | 4.4 | 4.6 | 35.4 | 43.7 | 34.8 | 4.00 | Q1 | 3/185 |
84 | 59 | Joule | 2024 | JOULE | CELL PRESS | 2542-4351 | 2542-4351 | 44869 | 146 | 183 | 4.4 | 4.6 | 35.4 | 43.7 | 34.8 | 4.00 | Q1 | 3/185 |
85 | 59 | Joule | 2024 | JOULE | CELL PRESS | 2542-4351 | 2542-4351 | 44869 | 146 | 183 | 4.4 | 4.6 | 35.4 | 43.7 | 34.8 | 4.00 | Q1 | 3/185 |
86 | 60 | Nature Nanotechnology | 2024 | NAT NANOTECHNOL | NATURE PORTFOLIO | 1748-3387 | 1748-3395 | 80966 | 195 | 208 | 7.1 | 6.0 | 34.9 | 40.4 | 34.6 | 5.00 | Q1 | 8/460 |
87 | 60 | Nature Nanotechnology | 2024 | NAT NANOTECHNOL | NATURE PORTFOLIO | 1748-3387 | 1748-3395 | 80966 | 195 | 208 | 7.1 | 6.0 | 34.9 | 40.4 | 34.6 | 5.00 | Q1 | 8/460 |
88 | 61 | Annual Review of Pathology-Mechanisms of Disease | 2024 | ANNU REV PATHOL-MECH | ANNUAL REVIEWS | 1553-4006 | 1553-4014 | 9486 | 0 | 22 | 6.7 | 7.4 | 34.5 | 39.7 | 34.4 | 6.80 | Q1 | 1/90 |
89 | 62 | Molecular Cancer | 2024 | MOL CANCER | BMC | N/A | 1476-4598 | 42332 | 124 | 218 | 4.6 | 4.9 | 33.9 | 35.9 | 33.3 | 5.04 | Q1 | 4/319 |
90 | 62 | Molecular Cancer | 2024 | MOL CANCER | BMC | N/A | 1476-4598 | 42332 | 124 | 218 | 4.6 | 4.9 | 33.9 | 35.9 | 33.3 | 5.04 | Q1 | 4/319 |
91 | 63 | Cancer Discovery | 2024 | CANCER DISCOV | AMER ASSOC CANCER RESEARCH | 2159-8274 | 2159-8290 | 36517 | 98 | 108 | 5.1 | 5.8 | 33.3 | 33.0 | 32.8 | 6.22 | Q1 | 10/326 |
92 | 63 | Annual Review of Immunology | 2024 | ANNU REV IMMUNOL | ANNUAL REVIEWS | 0732-0582 | 1545-3278 | 19882 | 0 | 25 | 11.5 | 7.7 | 33.3 | 37.7 | 33.2 | 3.64 | Q1 | 2/183 |
93 | 65 | iMeta | 2024 | IMETA | WILEY | 2770-5986 | 2770-596X | 3418 | 50 | 56 | 2.1 | 5.6 | 33.2 | 33.2 | 32.0 | 5.37 | Q1 | 2/163 |
94 | 66 | Nature Reviews Neurology | 2024 | NAT REV NEUROL | NATURE PORTFOLIO | 1759-4758 | 1759-4766 | 22117 | 3 | 48 | 6.2 | 5.5 | 33.1 | 43.4 | 32.8 | 5.70 | Q1 | 2/285 |
95 | 67 | JOURNAL OF HEPATOLOGY | 2024 | J HEPATOL | ELSEVIER | 0168-8278 | 1600-0641 | 64858 | 146 | 159 | 5.9 | 5.6 | 33.0 | 28.1 | 31.7 | 6.33 | Q1 | 3/147 |
96 | 68 | Nature Photonics | 2024 | NAT PHOTONICS | NATURE PORTFOLIO | 1749-4885 | 1749-4893 | 61047 | 150 | 158 | 7.7 | 6.3 | 32.9 | 38.2 | 32.3 | 7.47 | Q1 | 1/125 |
97 | 68 | Nature Photonics | 2024 | NAT PHOTONICS | NATURE PORTFOLIO | 1749-4885 | 1749-4893 | 61047 | 150 | 158 | 7.7 | 6.3 | 32.9 | 38.2 | 32.3 | 7.47 | Q1 | 1/125 |
98 | 69 | Lancet Respiratory Medicine | 2024 | LANCET RESP MED | ELSEVIER SCI LTD | 2213-2600 | N/A | 22960 | 58 | 67 | 4.5 | 5.1 | 32.8 | 35.4 | 32.6 | 8.78 | Q1 | 1/108 |
99 | 69 | Lancet Respiratory Medicine | 2024 | LANCET RESP MED | ELSEVIER SCI LTD | 2213-2600 | N/A | 22960 | 58 | 67 | 4.5 | 5.1 | 32.8 | 35.4 | 32.6 | 8.78 | Q1 | 1/108 |
100 | 70 | Nature Reviews Rheumatology | 2024 | NAT REV RHEUMATOL | NATURE PORTFOLIO | 1759-4790 | 1759-4804 | 17758 | 10 | 55 | 6.1 | 5.9 | 32.7 | 35.7 | 32.2 | 5.44 | Q1 | 1/58 |